David Frederick
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis
Papers in
- Hepatology 10
- Hepatitis C virus research 10
- Epidemiology 15
- Hepatitis B Virus Studies 15
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Franck S. Rousseau (14 shared papers)Merle G. Paule (10 shared papers)Ting‐Tsung Chang (3 shared papers)Patrick Marcellin (7 shared papers)Katyna Borroto–Esoda (7 shared papers)Michael P. Gillam (7 shared papers)Myron John Tong (2 shared papers)Seng Gee Lim (1 shared paper)
- Journals
- Pharmacology Biochemistry and Behavior (5 papers)Journal of Hepatology (3 papers)Hepatology (3 papers)The Journal of Clinical Pharmacology (2 papers)CHEST Journal (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
David Frederick
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 80
- Hepatology 566
- Toxicology 115
- Epidemiology 807
- Cellular and Molecular Neuroscience 189
- Pharmacology 98
Countries citing papers authored by David Frederick
This map shows the geographic impact of David Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Frederick more than expected).
Fields of papers citing papers by David Frederick
This network shows the impact of papers produced by David Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Frederick. The network helps show where David Frederick may publish in the future.
Co-authors
The 25 scholars most cited alongside David Frederick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 256 | |
| 2 | 2010 | 250 | |
| 3 | 2010 | 125 | |
| 4 | 2008 | 84 | |
| 5 | 1986 | 66 | |
| 6 | 1997 | 44 | |
| 7 | 2007 | 43 | |
| 8 | 1996 | 41 | |
| 9 | 1995 | 40 | |
| 10 | 1986 | 37 | |
| 11 | 1995 | 36 | |
| 12 | 2003 | 32 | |
| 13 | Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment. | 1998 | 26 |
| 14 | 1995 | 25 | |
| 15 | 1998 | 24 | |
| 16 | 1995 | 22 | |
| 17 | 1995 | 22 | |
| 18 | 2012 | 20 | |
| 19 | 2008 | 20 | |
| 20 | 2008 | 17 |
About David Frederick
David Frederick is a scholar working on Hepatology, Epidemiology, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Pharmacology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Memory and Neural Mechanisms (6 papers), HIV/AIDS drug development and treatment (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Hepatology (566 citations), Toxicology (115 citations), Epidemiology (807 citations), Cellular and Molecular Neuroscience (189 citations) and Pharmacology (98 citations). David Frederick has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Franck S. Rousseau, Merle G. Paule, Ting‐Tsung Chang, Patrick Marcellin, Katyna Borroto–Esoda, Michael P. Gillam, Myron John Tong, Seng Gee Lim, Sarah Arterburn and William Sievert. Their work appears in journals such as Pharmacology Biochemistry and Behavior, Journal of Hepatology, Hepatology, The Journal of Clinical Pharmacology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.